Krutika Kuppalli, MD FIDSA sur Twitter :
▻https://twitter.com/KrutikaKuppalli/status/1456744461090889735
Everyone is getting excited about oral #antiviral therapeutics for #COVID19 - a few things to consider
1. They have a novel mechanism of action and should be evaluated to ensure they are safe
2. We should see all the data for these drugs and stop data by press release
3. We need to understand things like risk of variants and long term complications with #molnupiravir
4.#Paxlovid is combined with #ritonavir a drug used in #HIV which is difficult to tolerate and has many drug interactions - so may have limited utility in high risk groups
